“MEASURED - REAL VALUES OF INTRAOCULAR TENSION, 24 H AFTER THE APPLICATION OF BROLUCIZUMAB INTRAVITREAL INJECTION IN PATIENTS WITH wAMD” (2024) MEDIS – International Journal of Medical Sciences and Research, 3(3), pp. 23–26. doi:10.35120/medisij030323h.